Losartan Potassium Tablet, Film Coated
FDA Label NDC 0615-7958

36 label sections · Submitted to the FDA by Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Ncs Healthcare Of Ky, Llc Dba Vangard Labs for the product Losartan Potassium (NDC 0615-7958). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 hypertension, 1.2 hypertensive patients with left ventricular hypertrophy, 1.3 nephropathy in type 2 diabetic patients, 2.1 hypertension, 2.2 hypertensive patients with left ventricular hypertrophy, 2.3 nephropathy in type 2 diabetic patients, 2.4 dosage modifications in patients with hepatic impairment, 2.5 preparation of suspension (for 200 ml of a 2.5 mg/ml suspension), and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.